Back to search

Article

Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing Nrf2-Tet1-AKR1C1-Mediated Progestin Metabolism

2021-05-07

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold>Progestin resistance is the main obstacle for the conservative therapy to maintain fertility in women with endometrial hyperplasia and cancer. Up to 30% of endometrial cancers fail to respond to progestin, a rate that has not significantly changed due to the lack of a detailed understanding of progestin resistance.<bold>Methods</bold>Cell Counting Kit-8 (CCK-8) as...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9a8c905f-a4d3-58dc-a39c-20fa3c1606ef
DOI
10.21203/rs.3.rs-427970/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Brusatol Sensitizes Endometrial Hyperplasia and Cancer to Progestin by Suppressing Nrf2-Tet1-AKR1C1-Mediated Progestin MetabolismDOI 10.21203/rs.3.rs-427970/v1
Select a neighboring publication to make it the new centre.